Keratins turn over by ubiquitination in a phosphorylation-modulated fashion

Journal of Cell Biology

Volumn 149, Issue 3, 2000, Pages 547-552

  Ku, Nam On ^a,b   Omary, M Bishr ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Intermediate filaments; Keratins; Mallory bodies; Phosphorylation; Ubiquitination

Indexed keywords

COMPLEMENTARY DNA; KERATIN; KERATIN 18; KERATIN 8; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ENZYME INHIBITION; HUMAN; MALLORY BODY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATORY MECHANISM;

CELL LINE; CYSTEINE ENDOPEPTIDASES; ENZYME INHIBITORS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATINS; LEUPEPTINS; MULTIENZYME COMPLEXES; MUTATION; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSFECTION; UBIQUITINS;

EID: 0034194388     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.149.3.547     Document Type: Article

References (34)

1. Akamatsu, M., S. Hori, Y. Tsutsumi, R.Y. Osamura, and M. Ohkido. 1995. Ubiquitinated cytokeratin inclusions in lichen amyloidosus: an immunohistochemical analysis. Pathol. Int. 45:116-122.
2. Cadrin, M., N.M. Anderson, L.H. Aasheim, H. Kawahara, D.J. Franks, and S.W. French. 1995. Modifications in cytokeratin and actin in cultured liver cells derived from griscofulvin-fed mice. Lab. Invest. 72:453-160.
3. Caulin, C., G.S. Salvesen, and R.G. Oshima. 1997. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell. Biol. 138:1379-1394.
4. Chehab, N.H., A. Malikzay, E.S. Stavridi, and T.D. Halazonetis. 1999. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl. Acad. Sci. USA. 961:13777-13782.
5. Chipev, C.C., B.P. Korge, N. Markova, S.J. Bale, J.J. DiGiovanna, J.G. Compton, and P.M. Steinen. 1992. A leucine→proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell. 70:821-828.
6. Chou, C.-F., A.J. Smith, and M.B. Omary. 1992. Characterization and dynamics of O-linked glycosylalion of human cylokeratin 8 and 18, J. Biol. Chem. 267: 3901-3906.
7. Chou, C.-F., C.L. Riopel, L.S. Rott, and M.B. Omary. 1993. A significant soluble keratin fraction in "simple" epithelial cells: Lack of an apparent phosphorylation and glycosylation role in keratin solubility. J. Cell Sci. 105:433-445.
8. Denk, H., E. Lackinger, K. Zatloukal, and W.W. Franke. 1987. Turnover of cytokeratin polypeptides in mouse hepatocytes. Exp. Cell Res. 173:137-143.
9. Fuchs, F., and K. Weber. 1994. Intermediate filaments: structure, dynamics, function and disease. Annu. Rev. Biochem. 63:345-382.
10. Fuchs, E., and D.W. Cleveland. 1998. A structural scaffolding of intermediate filaments in health and disease. Science. 279:514-519.
11. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425-479.
12. Hutter, H., K. Zatloukal, G. Winter, C. Stumptner, and H. Denk. 1993. Disturbance of keratin humeostasis in griseofulvin-intoxicated mouse liver. Lab. Invest. 69:576-582.
13. Jensen, K., and C. Gluud. 1994. The Mallory body: morphological, clinical and experimental studies. Hepatology. 20:1061-1077.
14. Johnston, J.A., C.L. Ward, and R.R. Kopito. 1998. Aggresomes: a cellular response to misfolded proteins. J Cell Biol. 143:1883-1898.
15. Ku, N.-O., and M.B. Omary. 1994. Identification of the major physiologic phosphorylation site of human keratin 18: potential kinases and a role in filament reorganization. J. Cell Biol. 127:161-171.
16. Ku, N.-O., and M.B. Omary. 1997. Phosphorylation of human keratin 8 in vivo at conserved head domain serine 23 and at epidermal growth factor-stimulated tail domain serine 431. J. Biol. Chem. 272:7556-7564.
17. Ku, N.-O., J. Liao, and M.B. Omary. 1997. Apoptosis generates stable fragments of human type 1 keratins. J. Biol. Chem. 272:33197-33203.
18. Ku, N.-O., J. Liao, and M.B. Omary. 1998a. Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. EMBO (Eur. Mol. Biol. Organ.) J. 17:1892-1906.
19. Ku, N.-O., S.A. Michie, R.M. Soetikno, E.Z. Resurreccion, R.L. Broome, and M.B Omary. 1998b. Mutation of a major keratin phosphorylation site predisposes to hepatotoxic injury in transgenic mice. J. Cell Biol. 143:2023-2032.
20. Ku, N.-O., X. Zhou, D.M. Toivola, and M.B. Omary. 1999. The cytoskeleton of digestive epithelia in health and disease. Am. J. Physiol. 277:G1108-G1137.
21. Laney, J.D., and M. Hochstrasser. 1999. Substrate targeting in the ubiquitin system. Cell. 97:427-430.
22. Liao, J., L.A. Lowthert, N.-O. Ku, R. Fernandez, and M.B. Omary. 1995. Dynamics of human keratin 18 phosphorylation: Polarized distribution of phosphorylated keratins in simple epithelial tissues. J. Cell Biol. 131:1241-1301.
23. Liao, J., N.-O. Ku, and M.B. Omary. 1997. Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at ser73 in tissues and cultured cells. J. Biol. Chem. 272:17565-17573.
24. Lowe, J., A. Blanchard, K. Morrell, G. Lennox, L. Reynolds, M. Billett, M. Landon, and R.J. Mayer. 1988. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J. Pathol. 155:9-15.
25. Moll, R., W.W. Franke, D.I., Schiller, B. Geiger, and R. Krepler. 1982. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 31:11-24.
26. Montes, J.F., G. Estrada, M.D. Lopez-Tejero, and J. Garcia-Valero. 1996. Changes in the enterocyte cytoskeleton in newborn rats exposed to ethanol in utero. Gut. 38:846-852.
27. Muller, F.B., W. Kuster, L. Bruckner-Tuderman, and B.P. Korge. 1998. Novel K5 and K14 mutations in German patients with the Weber-Cockayne variant of epidermolysis bullosa simplex. J. Invest. Dermatol. 111:900-902.
28. Musti, A.M., M. Treier, and D. Bohmann. 1997. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science. 275: 400-402.
29. Nishibori, U., Y. Matsuno, M. Iwaya, T. Osada, N. Kubomura, A. Iwamatsu, H. Kohno, S. Sato, M. Kitajima, and S. Hirohashi. 1996. Human colorectal carcinomas specifically accumulate Mr 42,000 ubiquitin-conjugated cytokeratin 8 fragments. Cancer Res. 56:2752-2757.
30. Ohta, M., N. Marceau, G. Perry, V. Manetto, P. Gambetti, L. Autilio-Gambetti, J. Metuzals, H. Kawahara, M. Cadrin, and S.W. French. 1988. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab. Invest. 59:848-856.
31. Okazaki, K., and N. Sagata. 1995. The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO (Eur. Mol. Biol. Organ.) J. 14:5048-5059.
32. Omary, M.B., N.-O. Ku, J. Liao, and D. Price. 1998. Keratin modifications and soluble properties in epithelial cells and in vitro. Subcell. Biochem. 31:105-139.
33. Stumptner, C., M.B. Omary, H. Denk, and K. Zatloukal. 2000. Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a Mallory body mouse model. Am. J. Pathol. 156:77-90.
34. Zhang, Y., and R.J. Schneider. 1994. Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network. J. Viro. 68:2544-2555.